专题：Neurological disorders and treatments

This cluster of papers focuses on the use of deep brain stimulation (DBS) for neurological disorders such as Parkinson's disease, treatment-resistant depression, epilepsy, and dystonia. The research explores the effects of DBS on the subthalamic nucleus, basal ganglia circuitry, and the treatment outcomes for various neurological conditions.
最新文献
Intestinal macrophages modulate synucleinopathy along the gut–brain axis

article Full Text OpenAlex

US FDA approves home-delivered tDCS for treating depression

article Full Text OpenAlex

Exploring Parkinson's disease: an insightful overview

book-chapter Full Text OpenAlex

Primary Brain Calcification: An International Consensus on Nomenclature, Diagnosis, Evaluation, and Management

article Full Text OpenAlex

Bipolar Disorder as a Long‐Term Risk Factor for Parkinson's Disease: A Nationwide Case–Control Study

article Full Text OpenAlex

Lower limb motor effects of DBS neurofeedback in Parkinson’s disease assessed through IMU-based UPDRS movement quality metrics

article Full Text OpenAlex

Region-specific variations in the cerebrovasculature underlie disease progression in Parkinson's disease

article Full Text OpenAlex

Spatiotemporal patterns differentiate hippocampal sharp-wave ripples from interictal epileptiform discharges in mice and humans

article Full Text OpenAlex

Precision at Deep Brain: Noninvasive Temporal Interference Stimulation

article Full Text OpenAlex

Non-invasive temporal interference stimulation of the hippocampus suppresses epileptic biomarkers in patients with Epilepsy: biophysical differences between kilohertz and amplitude modulated stimulation

article Full Text OpenAlex

近5年高被引文献
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy

review Full Text OpenAlex 715 FWCI81.2901

Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction

review Full Text OpenAlex 642 FWCI132.9683

Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study

article Full Text OpenAlex 629 FWCI130.0596

A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research

review Full Text OpenAlex 498 FWCI185.9242

Structures of α-synuclein filaments from human brains with Lewy pathology

article Full Text OpenAlex 449 FWCI52.4085

A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria

review Full Text OpenAlex 442 FWCI165.6415

Treatment of Glabellar Frown Lines with C. Botulinum-A Exotoxin

book-chapter Full Text OpenAlex 436 FWCI3.8059

Trial of Prasinezumab in Early-Stage Parkinson’s Disease

article Full Text OpenAlex 368 FWCI43.6977

Genetics and Pathogenesis of Parkinson's Syndrome

review Full Text OpenAlex 368 FWCI43.1997

Causal mapping of human brain function

review Full Text OpenAlex 316 FWCI34.4236